• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种C1q-ABO-ELISA以检测人抗A同种抗体与C1q的结合。

Development of a C1q-ABO-ELISA to measure C1q binding by human anti-A alloantibodies.

作者信息

von Allmen E, Rieben R, Nydegger U E

机构信息

Regional Red Cross Blood Transfusion Center, University of Berne, Switzerland.

出版信息

J Immunol Methods. 1994 May 2;171(1):85-92. doi: 10.1016/0022-1759(94)90231-3.

DOI:10.1016/0022-1759(94)90231-3
PMID:8176240
Abstract

Little is known about the correlation between the amount of anti-A antibodies and the respective complement activating capacity. We have therefore developed a new ELISA procedure for the study of complement activation by anti-A antibodies bound to immobilized blood group substance A through the classical pathway. C1q binding capacity of anti-A was then compared to both anti-A immunoglobulin (Ig) isotype serum concentrations and to the hemolysing capacity of O type sera. We have demonstrated that sera with low anti-A IgG and IgM levels produced low C1q binding activity and no hemolysis of human A1 red blood cells (RBC), whereas higher anti-A Ig levels resulted in either weak or strong C1q binding capacity as well as weak or strong RBC hemolysis. A correlation of rs = 0.755 was observed between C1q-ABO-ELISA and hemolysin assay results, although only 58% of the O type sera containing C1q binding anti-A lysed A1 type RBC under the used conditions. The C1q-ABO-ELISA is therefore a more sensitive assay for detecting 'dangerous' O type donors for blood transfusion to A type recipients than screening tests for hemolytic anti-A or determination of anti-A Ig levels alone.

摘要

关于抗A抗体量与各自补体激活能力之间的相关性,目前所知甚少。因此,我们开发了一种新的酶联免疫吸附测定(ELISA)方法,用于研究通过经典途径与固定化血型物质A结合的抗A抗体所引发的补体激活。然后将抗A的C1q结合能力与抗A免疫球蛋白(Ig)同种型血清浓度以及O型血清的溶血能力进行比较。我们已经证明,抗A IgG和IgM水平较低的血清产生的C1q结合活性较低,并且不会使人A1红细胞(RBC)发生溶血,而较高的抗A Ig水平则导致C1q结合能力弱或强,以及RBC溶血弱或强。尽管在所用条件下,只有58%含有C1q结合抗A的O型血清能使A1型RBC发生溶血,但在C1q-ABO-ELISA与溶血素测定结果之间观察到rs = 0.755的相关性。因此,对于检测向A型受血者输血的“危险”O型献血者而言,C1q-ABO-ELISA是一种比单独的抗A溶血筛查试验或抗A Ig水平测定更为灵敏的检测方法。

相似文献

1
Development of a C1q-ABO-ELISA to measure C1q binding by human anti-A alloantibodies.开发一种C1q-ABO-ELISA以检测人抗A同种抗体与C1q的结合。
J Immunol Methods. 1994 May 2;171(1):85-92. doi: 10.1016/0022-1759(94)90231-3.
2
The complement-activating capacity of maternal IgG antibodies to blood group A in paired mother/child serum samples.母婴配对血清样本中母体抗A血型IgG抗体的补体激活能力。
Vox Sang. 1998;74(2):95-100.
3
Interactions in the complement-mediated lysis of blood group AB erythrocytes sensitized simultaneously with anti-A and anti-B monoclonal antibodies.补体介导的同时用抗A和抗B单克隆抗体致敏的AB血型红细胞溶解中的相互作用。
Immunol Lett. 1993 Mar;35(3):219-28. doi: 10.1016/0165-2478(93)90186-6.
4
C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants.在“减少血小板同种免疫试验”研究参与者中,C1q结合抗HLA抗体不能预测血小板输注失败。
Transfusion. 2016 Jun;56(6):1442-50. doi: 10.1111/trf.13598. Epub 2016 Apr 15.
5
C1q aggregate binding for the determination of anti-complementary activity of immunoglobulin products.用于测定免疫球蛋白产品抗补体活性的C1q聚集体结合试验
Biologicals. 2011 Jan;39(1):38-42. doi: 10.1016/j.biologicals.2010.11.002. Epub 2011 Jan 21.
6
Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.固相补体(C1q)固定筛选 HLA 抗体可增加适合难治性患者的相容血小板成分的供应。
Transfusion. 2011 Dec;51(12):2611-8. doi: 10.1111/j.1537-2995.2011.03194.x. Epub 2011 May 26.
7
Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.三种检测方法(CIF-ELISA、C1q-ELISA和抗C3 ELISA)检测循环免疫复合物数量的比较研究
J Immunol Methods. 2001 Jul 1;253(1-2):13-21. doi: 10.1016/s0022-1759(01)00370-2.
8
Binding of complement component C1q to anti-beta2 glycoprotein I antibodies from patients with antiphospholipid syndrome.补体成分C1q与抗磷脂综合征患者抗β2糖蛋白I抗体的结合。
Inflamm Res. 1999 Oct;48(10):524-6. doi: 10.1007/s000110050497.
9
C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.有或无抗体介导排斥反应的肾移植受者中新生供者特异性 HLA 抗体的 C1q 结合活性
Transplantation. 2015 Jun;99(6):1151-5. doi: 10.1097/TP.0000000000000699.
10
Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.补体成分 C1q 和 C4 与循环免疫复合物结合在幼年特发性关节炎中的意义:支持经典补体途径的激活。
Clin Exp Rheumatol. 2011 Nov-Dec;29(6):1049-56. Epub 2011 Dec 22.

引用本文的文献

1
Adverse effects of intravenous immunoglobulin therapy.
Drug Saf. 1999 Sep;21(3):171-85. doi: 10.2165/00002018-199921030-00003.